Cell & Gene Therapy

A double helix of DNA made up of musical notes The notes are in black against a grey-white background
Biotech

Tune Tx's $175M series B to fund epigenetic HBV therapy's trials

Investors clearly appreciate the song that Tune Therapeutics is singing, handing over $175 million in series B funds.
James Waldron Jan 13, 2025 8:23am
Gloved hand grabbing frozen samples out of lab freezer

Moffitt strikes biorepository pact for Florida research campus

Jan 13, 2025 7:45am
Warren Biddle

JPM25: Kyverna CEO sets priorities for CAR-T autoimmune biotech

Jan 13, 2025 7:30am
water over rocks

Bayer moves allogeneic cell therapy into ph. 3 Parkinson's trial

Jan 13, 2025 2:30am
water tap outside

4DMT restructures pipeline, extending cash runway through 2028

Jan 10, 2025 2:00pm
layoffs job cuts workforce reduction layoff

Intellia cuts 27% of staff as it takes ax to pipeline

Jan 10, 2025 4:00am
More News

Astellas stops development of early-stage lymphoma CAR-T

Jan 9, 2025 6:49am

Gene editor Scribe slims down workforce as it readies for clinic

Jan 8, 2025 5:33pm

Sana stock price triples after allogeneic cell therapy data drop

Jan 8, 2025 10:38am

Galapagos splits in 2, laying off 40% of staff

Jan 8, 2025 4:49am